Tag: personalized medicine

June 26, 2019

6 Top Genetic Testing Stocks

Looking to invest in genetic testing? Or learn more about the companies involved? Here are six genetic testing stocks to...
February 28, 2019

Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized Immunotherapies

Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy
December 6, 2018

Myriad Validates Polygenic Score to Predict Breast Cancer Risk

Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the...
November 2, 2018

Myriad Presents Two New Studies at the Western Section of the American Urological Association

Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, today announced new data from two studies presented at the Western...
October 19, 2018

New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab

Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, today announced new data from two studies of Vectra that evaluated the...
October 10, 2018

Myriad Announces New Laboratory Agreement with Pfizer

Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, announced today that it has signed a new laboratory services agreement...
June 28, 2018

5 Top NASDAQ Genetic Stocks of Q2 2018

In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at...